NEW YORK (TheStreet) -- Strong charts continue to be found in this uncertain market, especially in the biotechs. Here are three to watch for more upside.
Arrowhead Research (ARWR) is in a bottoming pattern. It pulled back to test support in late July, and has since stair-stepped its way up. It reached initial lateral resistance recently, backed off, and then broke through it, consolidating this past week. On Wednesday, it was up 77 cents, or 4.77%, to $16.90 on nearly three million shares. If it can get through the $17.45 area, and looks like it could take a run to $18.50-$18.75, and then the low $20s. At around $16, shares are up over 50% for the year to date.
Read More: 7 Stocks Warren Buffett Is Selling in 2014
BioDelivery Sciences International (BDSI) is also acting great. After a one-day pullback, the stock has started to consolidate. On Wednesday, it gained 41 cents, or 2.39%, to $17.55 on 1.2 million shares. That's not very big volume for this stock, so it may continue to consolidate for another few days. Watch to see it flag in here before its next move to the high teens, maybe $20. Shares, at around $17.60 currently, are up 198% year to date.
Chimerix (CMRX) is another biotech that is happening. It has multiple tops a couple years apart, which it blew through on Wednesday, up $1.49, or 17.6%,to 30.03 on nearly a million shares. That's the biggest volume on an up-day in a year, or longer. It looks like it's headed up toward the mid $30s. Currently around $29.40, shares are up nearly 95% for the year todate.